Free Trial
LON:MPH

Mereo BioPharma Group plc (MPH.L) (MPH) Share Price, News & Analysis

GBX 26.50
-0.50 (-1.85%)
(As of 12/17/2020)
Today's Range
26
26.50
50-Day Range
26.50
26.50
52-Week Range
13
60
Volume
49,264 shs
Average Volume
333,975 shs
Market Capitalization
£89.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
MPH stock logo

About Mereo BioPharma Group plc (MPH.L) Stock (LON:MPH)

Mereo BioPharma Group plc, a biopharmaceutical company, acquires, develops, and commercializes therapeutics for the treatment of oncology and rare diseases. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor. The company also develops Navicixizumab (OMP-305B83) that is in Phase 1a clinical trial for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that has completed Phase II clinical trial to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), a novel antibody, which is in Phase IIb clinical trial for the treatment of osteogenesis imperfect; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 antitrypsin deficiency. Mereo BioPharma Group plc was founded in 2015 and is based in London, the United Kingdom.

MPH Stock Price History

MPH Stock News Headlines

Mereo BioPharma Group PLC ADR MREO
Mereo BioPharma Group PLC ADR
BTIG Keeps Their Buy Rating on Mereo Biopharma Group Plc (MREO)
Mereo BioPharma: Lagging Stock Despite Positive Data
Short Volatility Alert: Mereo Biopharma
See More Headlines
Receive MPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mereo BioPharma Group plc (MPH.L) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
9/29/2020
Today
5/22/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
50
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
GBX 17.12 per share
Book Value
GBX 7.20 per share

Miscellaneous

Free Float
N/A
Market Cap
£89.76 million
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Dr. Denise Scots-Knight (Age 61)
    Co-Founder, CEO & Exec. Director
    Comp: $751.37k
  • Mr. Charles Sermon (Age 51)
    Co-Founder, Gen. Counsel & Company Sec.
    Comp: $545.68k
  • Dr. Alastair MacKinnon (Age 50)
    Co-Founder & Chief Medical Officer
    Comp: $540.12k
  • Mr. John Richard (Age 63)
    Co-Founder & Head of Corp. Devel.
    Comp: $512.99k
  • Mr. Michael Stephen Wyzga MBA (Age 65)
    Interim CFO & Exec. Director
    Comp: $27.59k
  • Ms. Alexandra Hughes-Wilson (Age 49)
    Head of Patient Access & Commercial Planning
    Comp: $265.93k
  • Ms. Jill Henrich (Age 57)
    US Site Head & Sr. VP of Regulatory Affairs
    Comp: $286.93k
  • Dr. John A. Lewicki (Age 68)
    Chief Scientific Officer
  • Dr. Fiona Bor
    Head of Intellectual Property
  • Mr. Ian Hodgson
    Head of Clinical Operations

MPH Stock Analysis - Frequently Asked Questions

How have MPH shares performed in 2024?

Mereo BioPharma Group plc (MPH.L)'s stock was trading at GBX 26.50 at the beginning of the year. Since then, MPH shares have increased by 0.0% and is now trading at GBX 26.50.
View the best growth stocks for 2024 here
.

How were Mereo BioPharma Group plc (MPH.L)'s earnings last quarter?

Mereo BioPharma Group plc (MPH.L) (LON:MPH) issued its quarterly earnings results on Tuesday, September, 29th. The company reported ($105.00) earnings per share (EPS) for the quarter.

What other stocks do shareholders of Mereo BioPharma Group plc (MPH.L) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mereo BioPharma Group plc (MPH.L) investors own include Enanta Pharmaceuticals (ENTA), Advanced Micro Devices (AMD), American Tower (AMT), Inovio Pharmaceuticals (INO), Micron Technology (MU), Tesla (TSLA), Amgen (AMGN), ARMOUR Residential REIT (ARR), Arena Pharmaceuticals (ARNA) and Ardelyx (ARDX).

How do I buy shares of Mereo BioPharma Group plc (MPH.L)?

Shares of MPH stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:MPH) was last updated on 5/23/2024 by MarketBeat.com Staff

From Our Partners